The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


Immedica Pharma ABEU/1/98/095/002

Main Information

Trade NameEmadine
Active SubstancesEmedastine difumarate
Dosage FormEye drops, solution
Licence HolderImmedica Pharma AB
Licence NumberEU/1/98/095/002

Group Information

ATC CodeS01GX Other antiallergics


License statusAuthorised
Licence Issued27/01/1999
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back